Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort studyTrine Trab, Tarec Christoffer El‐Galaly, Joachim Bæch et al.|The Lancet Haematology|2023Cited by 27
Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based studyJoachim Bæch, Tarec Christoffer El‐Galaly, Sif Gudbrandsdottir et al.|British Journal of Haematology|2023Cited by 6
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Kirsten Grønbæk, Iman Chanchiri et al.|Blood Neoplasia|2025Cited by 4
<scp><i>NOTCH1</i></scp> Mutations Are Associated With Therapy‐Resistance in Patients With B‐Cell Lymphoma Treated With <scp>CD20xCD3</scp> Bispecific AntibodiesEmil Ramsø Kyvsgaard, Simon Husby, Morten Grauslund et al.|American Journal of Hematology|2025Cited by 4
Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodiesEmil Ramsø Kyvsgaard, Simon Husby, Trine Grantzau et al.|Blood Neoplasia|2025Cited by 2